Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 10 Relevant Journals, 29 Conferences, 5 National Symposiums are presently dedicated exclusively to Diabetic Neuropathy and about 15 articles are being published on Diabetic Neuropathy.
Diabetic Neuropathy is neuropathic disorders that are associated with diabetes mellitus. These conditions are thought to result from diabetic microvascular injury involving small blood vessels that supply nerves (vasa nervorum) in addition to macrovascular conditions that can culminate in diabetic neuropathy. Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy; mononeuropathy; mononeuropathy multiplex; diabetic amyotrophy; a painful polyneuropathy; autonomic neuropathy; and thoracoabdominal neuropathy. Diabetic neuropathy affects all peripheral nerves including pain fibers, motor neurons and the autonomic nervous system. It therefore can affect all organs and systems, as all are innervated. There are several distinct syndromes based upon the organ systems and members affected, but these are by no means exclusive. Symptoms vary depending on the nerve(s) affected and may include symptoms other than those listed. Symptoms usually develop gradually over years. Numbness and tingling of extremities, Dysesthesia (abnormal sensation to a body part), Diarrhea, Erectile dysfunction, Urinary incontinence (loss of bladder control), Facial, mouth and eyelid drooping, Vision changes, Dizziness, Muscle weakness are the symptoms.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and importance
Diabetic nephropathy is a common complication of diabetes and the leading cause of chronic kidney disease in the developed world. Approximately 40 % of persons with diabetes develop diabetic nephropathy, manifested as albuminuria and/or decreased glomerular filtration rate. Even mild degrees of albuminuria and decrease in glomerular filtration rate are associated with significantly increased risks of cardiovascular disease, end-stage renal disease, and premature deaths. The prevalence of diabetic nephropathy in the general population was not available from other countries. However, the prevalence of albuminuria in diabetes patients was reported in various populations. As the number of patients grows across the globe, there has never been a stronger and more urgent need for therapeutic measures that arrest the growth of the disease and alleviate its secondary manifestations.
Old content
Diabetic Neuropathy is neuropathic disorders that are associated with diabetes mellitus. These conditions are thought to result from diabetic microvascular injury involving small blood vessels that supply nerves (vasa nervorum) in addition to macrovascular conditions that can culminate in diabetic neuropathy. Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy; mononeuropathy; mononeuropathy multiplex; diabetic amyotrophy; a painful polyneuropathy; autonomic neuropathy; and thoracoabdominal neuropathy. Diabetic neuropathy affects all peripheral nerves including pain fibers, motor neurons and the autonomic nervous system. It therefore can affect all organs and systems, as all are innervated. There are several distinct syndromes based upon the organ systems and members affected, but these are by no means exclusive. Symptoms vary depending on the nerve(s) affected and may include symptoms other than those listed. Symptoms usually develop gradually over years. Numbness and tingling of extremities, Dysesthesia (abnormal sensation to a body part), Diarrhea, Erectile dysfunction, Urinary incontinence (loss of bladder control), Facial, mouth and eyelid drooping, Vision changes, Dizziness, Muscle weakness are the symptoms.
Market Analysis
Diabetic neuropathy is a neurological disorder associated with diabetes mellitus. The disorder affects all peripheral nerves including autonomic nervous system, pain fibres, and motor neurons. About 60 to 70 percent of people with diabetes have some form of neuropathy. According to a new technical market research report, 'Diabetes Therapies and Diagnostics' from BCC Research, the global market value for diabetes therapies and diagnostics is an estimated $38 billion in 2010, but is expected to increase to $51.2 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 6.1 percent. The largest segment of the market, insulin products (including administration devices), is estimated to be worth $16.4 billion in 2010, and is expected to increase at a CAGR of 6.1 per cent to reach $22 billion in 2015.
According to World Health Organization (WHO) approximately 350 million people worldwide suffer from diabetes and 80% of them live in low and middle income countries. Furthermore diabetic neuropathy affects 50% of the diabetic patients as per the data. Diabetes thus remains a burning issue in healthcare sector. Though symptoms of the disorder vary according to the nerves affected, common symptoms are abnormal sensations to body parts, erectile dysfunction, and loss of control over bladder, dizziness, muscle weakness, intense pain, speech impairment and others. Total cure for diabetic neuropathy does not exist, but therapeutic treatment can manage the related symptoms.
List of best International Conferences:
List of Related Societies
List of Related Companies
This page will be updated regularly.
This page was last updated on November 24, 2024
